Tag Archives: Fabrazyme

Fabry Disease Drug Shortage: Crisis Averted But No Long-Term Fix

By Amy Ritter. A critical drug that has experienced shortages is Genzyme’s Fabrazyme (agalsidase beta), the only enzyme replacement therapy approved in the US for Fabry disease. The drug was originally produced at the company’s Allston, Massachusetts plant. The Allston plant was plagued with quality problems, which resulted in a consent decree, temporary closure of […]
Posted in Guest Blog | Also tagged , , , | 1 Comment
  • Categories

  • Meta